Share
CBS News
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
By Khristopher J. Brooks | 5 Nov 2020
RELATED TOPICS:
Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud
3 hours ago
Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports
3 hours ago
Fresno County CHP Arrest Two in Interstate 5 Drug, Gun, and Counterfeit Money Bust
4 hours ago
Where Trade Talks Stand With Major US Partners Ahead of Tariffs-Hike Deadline
4 hours ago
DOJ Announces Arrest, Indictments in North Korean IT Worker Scheme
4 hours ago
Fresno Man Arrested in Clovis for Sex-Related Crimes Against Minor
4 hours ago
Clovis Police Seek Public’s Help in Finding Missing 82-Year-Old Woman
2 hours ago
Categories

Clovis Police Seek Public’s Help in Finding Missing 82-Year-Old Woman

Fresno Woman Killed in Head-On Collision, CHP Investigating

Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill

Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud

Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports
